Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands		Total	Common Shares	Class B Common Stock	Common Stock Common Shares	Common Stock Class B Common Stock	Capital Surplus	Retained Earnings	Retained Earnings Common Shares	Retained Earnings Class B Common Stock	Accumulated Other Comprehensive Loss
Balance at beginning of period at Aug. 27, 2022		$ 1,915,871			$ 1,508	$ 359	$ 93,131	$ 1,845,163			$ (24,290)
Balance at beginning as of period (in shares) at Aug. 27, 2022					15,075	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		33,957						33,957
Change in fair value of derivatives	[1]	52									52
Foreign currency translation		(1,778)									(1,778)
Dividends declared Common Stock			$ (4,680)	$ (890)					$ (4,680)	$ (890)
Share-based compensation, net	[2]	(567)					(567)
Share-based awards exercised, net	[1]	1			$ 1
Share-based awards exercised, net (in shares)	[1]				20
Balance at end of period at Nov. 26, 2022		1,941,966			$ 1,509	$ 359	92,564	1,873,550			(26,016)
Balance at end as of period (in shares) at Nov. 26, 2022					15,095	3,590
Balance at beginning of period at Aug. 27, 2022		1,915,871			$ 1,508	$ 359	93,131	1,845,163			(24,290)
Balance at beginning as of period (in shares) at Aug. 27, 2022					15,075	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		76,043
Foreign currency translation		(2,489)
Balance at end of period at May. 27, 2023		1,976,851			$ 1,510	$ 359	97,154	1,904,490			(26,662)
Balance at end as of period (in shares) at May. 27, 2023					15,103	3,590
Balance at beginning of period at Nov. 26, 2022		1,941,966			$ 1,509	$ 359	92,564	1,873,550			(26,016)
Balance at beginning as of period (in shares) at Nov. 26, 2022					15,095	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		17,810						17,810
Change in fair value of derivatives	[1]	59									59
Foreign currency translation		(1,473)									(1,473)
Dividends declared Common Stock			(4,682)	(890)					(4,682)	(890)
Share-based compensation, net	[2]	2,297					2,297
Share-based awards exercised, net	[1]	1			$ 1
Share-based awards exercised, net (in shares)	[1]				8
Balance at end of period at Feb. 25, 2023		1,955,088			$ 1,510	$ 359	94,861	1,885,788			(27,430)
Balance at end as of period (in shares) at Feb. 25, 2023					15,103	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		24,276						24,276
Change in fair value of derivatives	[1]	6									6
Foreign currency translation		762									762
Dividends declared Common Stock			(4,684)	(890)					(4,684)	(890)
Share-based compensation, net	[2]	2,293					2,293
Balance at end of period at May. 27, 2023		1,976,851			$ 1,510	$ 359	97,154	1,904,490			(26,662)
Balance at end as of period (in shares) at May. 27, 2023					15,103	3,590
Balance at beginning of period at Aug. 26, 2023		2,003,960			$ 1,510	$ 359	99,303	1,926,549			(23,761)
Balance at beginning as of period (in shares) at Aug. 26, 2023					15,104	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		42,325						42,325
Change in fair value of derivatives	[1]	(12)									(12)
Foreign currency translation		(151)									(151)
Dividends declared Common Stock			(4,993)	(948)					(4,993)	(948)
Repurchase of Common Stock		(255)					(10)	(245)
Repurchase of common stock (in shares)					(2)
Share-based compensation, net	[2]	244					244
Share-based awards exercised, net	[1]	3			$ 3
Share-based awards exercised, net (in shares)	[1]				26
Balance at end of period at Nov. 25, 2023		2,040,173			$ 1,513	$ 359	99,537	1,962,688			(23,924)
Balance at end as of period (in shares) at Nov. 25, 2023					15,128	3,590
Balance at beginning of period at Aug. 26, 2023		2,003,960			$ 1,510	$ 359	99,303	1,926,549			(23,761)
Balance at beginning as of period (in shares) at Aug. 26, 2023					15,104	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		100,839
Foreign currency translation		170
Balance at end of period at May. 25, 2024		2,075,608			$ 1,504	$ 359	103,097	1,994,279			(23,631)
Balance at end as of period (in shares) at May. 25, 2024					15,040	3,590
Balance at beginning of period at Nov. 25, 2023		2,040,173			$ 1,513	$ 359	99,537	1,962,688			(23,924)
Balance at beginning as of period (in shares) at Nov. 25, 2023					15,128	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		20,457						20,457
Change in fair value of derivatives	[1]	(34)									(34)
Foreign currency translation		919									919
Dividends declared Common Stock			(4,976)	(948)					(4,976)	(948)
Repurchase of Common Stock		(7,864)			$ (4)		(298)	(7,562)
Repurchase of common stock (in shares)					(45)
Share-based compensation, net	[2]	1,958					1,958
Share-based awards exercised, net (in shares)	[1]				4
Balance at end of period at Feb. 24, 2024		2,049,685			$ 1,509	$ 359	101,197	1,969,659			(23,039)
Balance at end as of period (in shares) at Feb. 24, 2024					15,087	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		38,057						38,057
Change in fair value of derivatives		6									6
Foreign currency translation		(598)									(598)
Dividends declared Common Stock			$ (4,961)	$ (948)					$ (4,961)	$ (948)
Repurchase of Common Stock		(7,844)			$ (5)		(311)	(7,528)
Repurchase of common stock (in shares)					(47)
Share-based compensation, net	[2]	2,211					2,211
Balance at end of period at May. 25, 2024		$ 2,075,608			$ 1,504	$ 359	$ 103,097	$ 1,994,279			$ (23,631)
Balance at end as of period (in shares) at May. 25, 2024					15,040	3,590

[1] These amounts are shown net of the effect of income taxes.

[2] These amounts are shown net of any shares withheld by the Company to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.